S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
How Much Longer Will It Be Under $1? (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
51-Year Market Veteran Reveals Stunning "Crash Profit Trades" (Ad)pixel
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
51-Year Market Veteran Reveals Stunning "Crash Profit Trades" (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
How Much Longer Will It Be Under $1? (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
51-Year Market Veteran Reveals Stunning "Crash Profit Trades" (Ad)pixel
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
51-Year Market Veteran Reveals Stunning "Crash Profit Trades" (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
How Much Longer Will It Be Under $1? (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
51-Year Market Veteran Reveals Stunning "Crash Profit Trades" (Ad)pixel
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
51-Year Market Veteran Reveals Stunning "Crash Profit Trades" (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
How Much Longer Will It Be Under $1? (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
51-Year Market Veteran Reveals Stunning "Crash Profit Trades" (Ad)pixel
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
51-Year Market Veteran Reveals Stunning "Crash Profit Trades" (Ad)pixel
NASDAQ:SIEN

Sientra - SIEN Stock Forecast, Price & News

$0.98
-0.24 (-19.64%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.90
$1.10
50-Day Range
$0.72
$1.39
52-Week Range
$0.70
$6.96
Volume
3.33 million shs
Average Volume
635,034 shs
Market Capitalization
$61.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.29

Sientra MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
641.9% Upside
$7.29 Price Target
Short Interest
Bearish
23.38% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.12mentions of Sientra in the last 14 days
Based on 13 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.93) to ($0.77) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.81 out of 5 stars

Medical Sector

933rd out of 1,135 stocks

Surgical Appliances & Supplies Industry

20th out of 23 stocks

SIEN stock logo

About Sientra (NASDAQ:SIEN) Stock

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

Sientra Stock Down 19.5 %

Shares of SIEN traded down $0.24 during mid-day trading on Friday, reaching $0.98. The company's stock had a trading volume of 3,333,678 shares, compared to its average volume of 635,034. The company's 50 day moving average is $0.95 and its 200 day moving average is $1.69. The stock has a market cap of $61.52 million, a PE ratio of -1.06 and a beta of 1.94. Sientra has a 12-month low of $0.70 and a 12-month high of $6.96. The company has a debt-to-equity ratio of 2.61, a current ratio of 1.59 and a quick ratio of 0.95.

Sientra (NASDAQ:SIEN - Get Rating) last announced its quarterly earnings results on Thursday, May 12th. The medical instruments supplier reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.03). Sientra had a negative net margin of 68.28% and a negative return on equity of 281.04%. The company had revenue of $21.40 million during the quarter, compared to analysts' expectations of $20.25 million. Equities analysts anticipate that Sientra will post -0.93 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have weighed in on SIEN. Canaccord Genuity Group cut their price target on Sientra from $8.00 to $5.00 in a report on Friday, May 13th. Maxim Group restated a "buy" rating and set a $5.00 target price on shares of Sientra in a research note on Friday, May 13th. Finally, StockNews.com downgraded shares of Sientra from a "hold" rating to a "sell" rating in a research note on Tuesday, May 10th. One investment analyst has rated the stock with a sell rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, Sientra has a consensus rating of "Moderate Buy" and a consensus price target of $7.29.

Receive SIEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sientra and its competitors with MarketBeat's FREE daily newsletter.

SIEN Stock News Headlines

Sientra (SIEN) Set to Announce Quarterly Earnings on Thursday
See More Headlines
Receive SIEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sientra and its competitors with MarketBeat's FREE daily newsletter.

SIEN Company Calendar

Last Earnings
11/10/2021
Today
8/14/2022
Next Earnings (Estimated)
11/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SIEN
Employees
319
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.29
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+641.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-62,480,000.00
Pretax Margin
-28.50%

Debt

Sales & Book Value

Annual Sales
$80.68 million
Book Value
$0.70 per share

Miscellaneous

Free Float
61,575,000
Market Cap
$61.52 million
Optionable
Optionable
Beta
1.94














SIEN Stock - Frequently Asked Questions

Should I buy or sell Sientra stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SIEN shares.
View SIEN analyst ratings
or view top-rated stocks.

What is Sientra's stock price forecast for 2022?

6 analysts have issued 12 month target prices for Sientra's stock. Their SIEN share price forecasts range from $5.00 to $10.00. On average, they expect the company's share price to reach $7.29 in the next year. This suggests a possible upside of 641.9% from the stock's current price.
View analysts price targets for SIEN
or view top-rated stocks among Wall Street analysts.

How have SIEN shares performed in 2022?

Sientra's stock was trading at $3.67 at the start of the year. Since then, SIEN shares have decreased by 73.2% and is now trading at $0.9821.
View the best growth stocks for 2022 here
.

When is Sientra's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our SIEN earnings forecast
.

How were Sientra's earnings last quarter?

Sientra, Inc. (NASDAQ:SIEN) announced its earnings results on Wednesday, November, 10th. The medical instruments supplier reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.26) by $0.18. The medical instruments supplier had revenue of $19.62 million for the quarter, compared to analyst estimates of $18.10 million. Sientra had a negative trailing twelve-month return on equity of 281.04% and a negative net margin of 68.28%. During the same quarter in the prior year, the business posted ($0.33) earnings per share.

What guidance has Sientra issued on next quarter's earnings?

Sientra issued an update on its FY 2022 earnings guidance on Friday, August, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $90.00 million-$95.00 million, compared to the consensus revenue estimate of $95.19 million.

What other stocks do shareholders of Sientra own?

What is Sientra's stock symbol?

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Who are Sientra's major shareholders?

Sientra's stock is owned by a number of institutional and retail investors. Top institutional investors include AWM Investment Company Inc. (3.50%), Needham Investment Management LLC (3.38%), Granite Point Capital Management L.P. (2.86%), First Light Asset Management LLC (2.29%), Mutual of America Capital Management LLC (1.52%) and Renaissance Technologies LLC (0.25%). Insiders that own company stock include Andrew C Schmidt, Andrew C Schmidt, Hove Caroline F Van, Jeffrey M Nugent, Oliver Christian Bennett, Paul Sean Little, Ronald Menezes and Valerie J Miller.
View institutional ownership trends
.

How do I buy shares of Sientra?

Shares of SIEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sientra's stock price today?

One share of SIEN stock can currently be purchased for approximately $0.98.

How much money does Sientra make?

Sientra (NASDAQ:SIEN) has a market capitalization of $61.52 million and generates $80.68 million in revenue each year. The medical instruments supplier earns $-62,480,000.00 in net income (profit) each year or ($0.93) on an earnings per share basis.

How many employees does Sientra have?

The company employs 319 workers across the globe.

How can I contact Sientra?

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The official website for the company is www.sientra.com. The medical instruments supplier can be reached via phone at (805) 562-3500, via email at ir@sientra.com, or via fax at 805-562-8401.

This page (NASDAQ:SIEN) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.